STRONGBRIDGE BIOPHARMA plc Long-Term Debt, Maturity, Year Four
STRONGBRIDGE BIOPHARMA plc had Long-Term Debt, Maturity, Year Four of $4.17 million as of 2020-12-31, per its 10-K filed 2021-03-03.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2021-03-03
- 2020-12-31: Long-Term Debt, Maturity, Year Four $4.17M.
- 2020-09-30: Long-Term Debt, Maturity, Year Four $2.08M.
- 2020-06-30: Long-Term Debt, Maturity, Year Four $3.33M.
- 2018-09-30: Long-Term Debt, Maturity, Year Four $35.32M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2020-12-31 | $4.17M 10-K · filed 2021-03-03 |
| 2020-09-30 | $2.08M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $3.33M 10-Q · filed 2020-08-04 |
| 2018-09-30 | $35.32M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $34.96M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $34.61M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $13.67M 10-K · filed 2018-03-12 |
| 2017-09-30 | $6.76M 6-K · filed 2017-11-14 |
| 2017-06-30 | $8.00M 6-K · filed 2017-08-07 |
| 2017-03-31 | $8.00M 6-K · filed 2017-05-16 |
| 2016-12-31 | $7.33M 20-F · filed 2017-04-04 |